Conjoined twins could be in their own home within weeks.
A high-tech screening tool for cervical cancer is facing pushback from more than a dozen patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.
The calorie counting that defined dieting for so long is giving way to other considerations, like the promise of more fiber or natural ingredients
In a north London hospital, scientists are growing noses, ears and blood vessels in a bold attempt to make body parts in the laboratory.
Undeclared allergen blamed for pulling products off store shelves
An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday.
A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.
There's fresh evidence that a lot of young people could be headed for heart trouble. A large study of preteens in Texas found that about one-third of them had borderline or high cholesterol when tested during routine physical exams.
A small study that examined brains from children who died found abnormal patterns of cell growth in autistic children. The research bolsters evidence that something before birth might cause autism, at least in some cases.
The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests which use DNA from a patient's stool to detect dangerous tumors and growths.
The Boise Fire Department, along with individual firefighter Rich T. Brown, have raised the most amount of money for the annual fundraiser for the Leukemia & Lymphoma Society.
Almost half of Americans ages 40 to 75 and nearly all men over 60 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines, an analysis concludes.
IBM said Wednesday that its Watson cloud computing system will be used in partnership with a New York-based genetic research center mainly to help sequence DNA for the treatment of glioblastoma, the most common type of brain cancer in U.S. adults.
It's not just grandma with a new hip and your uncle with a new knee. More than 2 of every 100 Americans now have an artificial joint, doctors are reporting.